Merck KGaA and Sigma-Aldrich Consolidation continued in the lab-products market, as less than a year after Thermo Fisher Scientific’s purchase of Life Technologies (see IBO 2/15/14), Merck KGaA announced a $17 billion deal to buy Sigma-Aldrich (see IBO 9/30/14). The deal highlights the importance of scale and diversification and transforms Merck/EMD Millipore into a major […]
A More Focused Approach As economic headwinds in China, industrial and selected government markets continued in 2014, several analytical-instrument and lab-product companies took steps to focus on a narrower set of businesses and product lines, in some cases, divesting assets and, in other cases, consolidating their positions. Among the year’s most prominent product-line exits were […]
San Diego, CA 1/12/15; San Francisco, CA 1/12/15; Washington, DC 1/12/15—At the annual JP Morgan Healthcare Conference, Illumina announced that its 2014 revenues grew 20%, following a 32% increase in the fourth quarter to $512 million. The company forecasts 2015 revenues to increase 20% and non-GAAP EPS of $3.12–$3.18. In addition, Illumina announced four new […]
Company Announcements Nabsys named Anthony Shuber as vice president and CSO in October. He was previously CTO and vice president of Ignyta. Under an October agreement with Illumina, HTG Molecular Diagnostics will have the right to develop IVD test kits that utilize Illumina sequencing technology. Sequenta and Illumina agreed in November to commercialize an IVD […]
Company Announcements GenoLogics was selected by Illumina in September as the preferred LIMS provider to support HiSeq X Ten sequencing-system customers. Nabsys named Steve Lombardi as president and CEO in September. Sunquest Information Systems and Partners Healthcare established a strategic alliance that includes a strategic investment by Sunquest in GeneInsight. SeqLL, which offers Helicos’ sequencing […]
Company Announcements Roche and the Garvan Institute of Medical Research announced in August a collaboration to develop new technologies for targeted epigenomic analysis. New England Biolabs exclusively in-licensed rights from Genomic Health to technology for the depletion of abundant DNA using RNase H–based depletion. Product Introductions In August, Coveris launched the micro TUBE LV for […]
Coinciding with ASHG 2014, several firms announced new partnerships in highly competitive markets. Affymetrix announced a multiyear supply agreement with Arosa Diagnostics, which will use Affymetrix instruments and arrays as part of its Harmony noninvasive prenatal test for Trisomy 21 in fetuses, allowing wider adoption of the test. Arosa’s DANSR (Digital Analysis of Selected Regions) […]
The 64th annual meeting of the American Society of Human Genomics was held October 18–22 in San Diego, California. The event attracted 8,433 attendees, including 6,566 scientific attendees (nonexhibitors), a 3.1% decrease from the 2013 show, which was held in Boston, Massachusetts. Two hundred forty companies exhibited, compared with 235 last year. In a Tuesday […]
Pleasanton, CA 10/9/14—Roche has acquired exclusive rights to target-discovery company AbVitro’s primer-extension–based target-enrichment (PETE) technology and associated patent applications. Financial details were not disclosed. PETE technology will be used to support Roche’s next-generation sequencing (NGS) directly from blood or other biological samples. The technology will be incorporated into the Sequencing Unit’s R&D pipeline to support […]
develop companion diagnostics. Thermo Fisher Scientific on September 25 announced a partnership with GlaxoSmithKline and Pfizer to develop an NGS oncology test for solid tumors. The test will be used as a companion diagnostic for several drug programs after premarket approval from the FDA and other regulatory agencies. The test will apply to CNVs, gene […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
